Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 5/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13578396 | 0.81 | MAPT (0.47) | NCEH1KDM4EGLAGAAPOLB | |
| SCHEMBL5004232 | 0.79 | PDK2 (0.43) | KDM4ECA9LMNACYP3A4MAPT | |
| SCHEMBL29403081 | 0.78 | PDK2 (0.44) | CA9 | |
| SCHEMBL204806 | 0.78 | PDK2 (0.44) | CA9 | |
| SCHEMBL29587737 | 0.78 | PDK2 (0.44) | CA9 | |
| SCHEMBL29061596 | 0.78 | ALK (0.34) | NCEH1CA9ALK | |
| SCHEMBL6536469 | 0.77 | METAP1 (0.45) | NCEH1KDM4EPOLBLMNACYP3A4 | |
| SCHEMBL14682554 | 0.77 | PDK2 (0.36) | CA9ALK | |
| SCHEMBL29061594 | 0.77 | ALK (0.37) | CA9ALK | |
| SCHEMBL4998169 | 0.76 | MAPT (0.47) | CA9LMNAMAPTALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080119499-A1 | Compositions Havinge Improved 2-Photon Absorbance For Nonlinear Applications | MEMPILE INC. (DE) | 2008-05-22 | — | — | US | disclosed |
| EP-1842097-A1 | COMPOUNDS HAVING IMPROVED 2-PHOTON ABSORBANCE FOR NONLINEAR APPLICATIONS | Mempile Inc. (US) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006075328-A1 | COMPOUNDS HAVING IMPROVED 2-PHOTON ABSORBANCE FOR NONLINEAR APPLICATIONS | MEMPILE INC. (US) | 2006-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119499-A1 | Compositions Havinge Improved 2-Photon Absorbance For Nonlinear Applications | HTR3D, CRY2, CNDP2 | NCEH1 1985/4885KDM4E 2254/4885CA12 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.